The National Institute on Drug Abuse (NIDA) is offering the Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) to early-stage investigators with innovative research proposals. This grant aims to support individuals lacking preliminary data for an R01 grant, focusing on substance abuse and HIV/AIDS research. Applicants should demonstrate potential as future leaders in the field, with the goal of improving interventions and therapies for substance-using populations at risk for HIV/AIDS. The deadline for applications is on November 14, 2016.
Opportunity ID: 253450
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | RFA-DA-15-007 |
| Funding Opportunity Title: | Avenir Award Program for Research on Substance Abuse and HIV/AIDS (DP2) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Education Health |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.279 — Drug Abuse and Addiction Research Programs |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Apr 04, 2014 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | Nov 14, 2016 |
| Current Closing Date for Applications: | Nov 14, 2016 |
| Archive Date: | Dec 15, 2016 |
| Estimated Total Program Funding: | $1,500,000 |
| Award Ceiling: | $300,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | State governments Special district governments Public housing authorities/Indian housing authorities Public and State controlled institutions of higher education Native American tribal governments (Federally recognized) City or township governments Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses For profit organizations other than small businesses Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts County governments Private institutions of higher education Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are not eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are not allowed. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Avenir means future in French, and this award looks toward the future by supporting early stage investigators proposing highly innovative studies. The award will support those in an early stage of their career who may lack the preliminary data required for an R01 grant, but who propose high impact research and who show promise of being tomorrow’s leaders in the field. NIDA has developed two Avenir Award Programs, one for HIV/AIDS research and the other for genetics or epigenetics studies. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support creative individuals who wish to pursue innovative research at the nexus of substance abuse and HIV/AIDS. The Avenir Award Program for Research on Substance Abuse and HIV/AIDS will support research approaches for substance using populations with or at risk for HIV/AIDS that may lead to improved preventive interventions, improved therapies and/or long term retention in care, and ultimately, eradication of HIV. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/rfa-files/RFA-DA-15-007.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| FORMS-C | Forms-C | PKG00194785 | Oct 12, 2014 | Jun 09, 2016 | View | |
| FORMS-D | Use for due dates on or after May 25, 2016 | PKG00224166 | Oct 14, 2016 | Nov 14, 2016 | View |
Package 1
Mandatory forms
253450 RR_SF424_2_0-2.0.pdf
253450 PHS398_ResearchPlan_2_0-2.0.pdf
253450 PHS398_CoverPageSupplement_2_0-2.0.pdf
253450 RR_KeyPersonExpanded_2_0-2.0.pdf
253450 RR_OtherProjectInfo_1_3-1.3.pdf
253450 PerformanceSite_2_0-2.0.pdf
Optional forms
253450 PHS398_CumulativeInclusionReport-1.0.pdf
253450 PlannedReport-1.0.pdf
Package 2
Mandatory forms
253450 RR_SF424_2_0-2.0.pdf
253450 PHS398_CoverPageSupplement_3_0-3.0.pdf
253450 RR_OtherProjectInfo_1_3-1.3.pdf
253450 PerformanceSite_2_0-2.0.pdf
253450 RR_KeyPersonExpanded_2_0-2.0.pdf
253450 PHS398_ResearchPlan_3_0-3.0.pdf
Optional forms
253450 PHS_Inclusion_Enrollment_Report-1.0.pdf
253450 PHS_AssignmentRequestForm-1.0.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
